Single User
£3750
PDF
82 pages

Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026


Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing blunt, penetrating or blast injuries to the brain. Injury can be focal or diffuse. Focal TBI tends to be caused by sudden contact (e.g. blow to the head) whereas diffuse TBI suggests an acceleration / deceleration event (e.g. motor vehicle accident). TBI does not include brain injury which develops as the result of a direct underlying condition which damages the brain (e.g. tumours).

This report provides the current Incident population for Traumatic Brain Injury across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Netherlands, Denmark, Finland, Norway, Sweden, Austria, Poland, Turkey, Brazil, Japan, China, India, Australia and South Africa) split by gender and 5-year age cohort. Along with the current Incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Traumatic Brain Injury have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Patients with TBI have an increased risk of developing a number of different conditions including:

  • Strokes and cerebral haemorrhage including;
    • Subdural haematoma
    • Epidural haematoma
    • Subarachnoid haemorrhage
    • Intracerebral haematoma
  • Mental health issues such as depression, panic and generalised anxiety disorder
  • Amnesia (post-traumatic and retrograde)
  • Impaired motor functionality

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
  • Able to quantify patient populations in global Traumatic Brain Injury market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Traumatic Brain Injury and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Traumatic Brain Injury's incident population.
  • Identify sub-populations within Traumatic Brain Injury which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Traumatic Brain Injury patients.
Table of Contents
  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Traumatic Brain Injury
  • Features of TBI patients
    • Main cause of TBI
    • Severity of TBI
    • Marshall CT Class of TBI
    • Outcome at 1 year
    • Clinical events and features of TBI patients
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix
List of Tables
  • Glasgow Coma Scale
  • Marshall CT classification for brain injury
  • Glasgow Outcome Scale
  • Incidence of TBI, males (000s)
  • Incidence of TBI, females (000s)
  • TBI by cause, total (000s)
  • TBI by severity, total (000s)
  • TBI by Marshall CT, total (000s)
  • TBI outcome at 1 year, total (000s)
  • TBI patients with hypoxia, total (000s)
  • TBI patients with hypotension, total (000s)
  • TBI patients with subarachnoid haemorrhage, total (000s)
  • TBI patients with subdural haematoma, total (000s)
  • TBI patients with epidural haematoma, total (000s)
  • TBI patients with Intra-cerebral haematoma, total (000s)
  • TBI patients with cerebral contusion(s), total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of TBI by 5-yr age cohort, males (000s)
  • USA Incidence of TBI by 5-yr age cohort, females (000s)
  • Canada Incidence of TBI by 5-yr age cohort, males (000s)
  • Canada Incidence of TBI by 5-yr age cohort, females (000s)
  • France Incidence of TBI by 5-yr age cohort, males (000s)
  • France Incidence of TBI by 5-yr age cohort, females (000s)
  • Germany Incidence of TBI by 5-yr age cohort, males (000s)
  • Germany Incidence of TBI by 5-yr age cohort, females (000s)
  • Italy Incidence of TBI by 5-yr age cohort, males (000s)
  • Italy Incidence of TBI by 5-yr age cohort, females (000s)
  • Spain Incidence of TBI by 5-yr age cohort, males (000s)
  • Spain Incidence of TBI by 5-yr age cohort, females (000s)
  • UK Incidence of TBI by 5-yr age cohort, males (000s)
  • UK Incidence of TBI by 5-yr age cohort, females (000s)
  • Netherlands Incidence of TBI by 5-yr age cohort, males (000s)
  • Netherlands Incidence of TBI by 5-yr age cohort, females (000s)
  • Denmark Incidence of TBI by 5-yr age cohort, males (000s)
  • Denmark Incidence of TBI by 5-yr age cohort, females (000s)
  • Finland Incidence of TBI by 5-yr age cohort, males (000s)
  • Finland Incidence of TBI by 5-yr age cohort, females (000s)
  • Norway Incidence of TBI by 5-yr age cohort, males (000s)
  • Norway Incidence of TBI by 5-yr age cohort, females (000s)
  • Sweden Incidence of TBI by 5-yr age cohort, males (000s)
  • Sweden Incidence of TBI by 5-yr age cohort, females (000s)
  • Austria Incidence of TBI by 5-yr age cohort, males (000s)
  • Austria Incidence of TBI by 5-yr age cohort, females (000s)
  • Poland Incidence of TBI by 5-yr age cohort, males (000s)
  • Poland Incidence of TBI by 5-yr age cohort, females (000s)
  • Turkey Incidence of TBI by 5-yr age cohort, males (000s)
  • Turkey Incidence of TBI by 5-yr age cohort, females (000s)
  • Brazil Incidence of TBI by 5-yr age cohort, males (000s)
  • Brazil Incidence of TBI by 5-yr age cohort, females (000s)
  • Japan Incidence of TBI by 5-yr age cohort, males (000s)
  • Japan Incidence of TBI by 5-yr age cohort, females (000s)
  • China Incidence of TBI by 5-yr age cohort, males (000s)
  • China Incidence of TBI by 5-yr age cohort, females (000s)
  • India Incidence of TBI by 5-yr age cohort, males (000s)
  • India Incidence of TBI by 5-yr age cohort, females (000s)
  • Australia Incidence of TBI by 5-yr age cohort, males (000s)
  • Australia Incidence of TBI by 5-yr age cohort, females (000s)
  • South Africa Incidence of TBI by 5-yr age cohort, males (000s)
  • South Africa Incidence of TBI by 5-yr age cohort, females (000s)
Australia, Austria, Brazil, Canada, China, Denmark, Finland, France, Germany, India, Italy, Japan, Netherlands, Norway, Poland, South Africa, Spain, Sweden, Turkey, United Kingdom, United States of America